Quantbot Technologies LP Makes New $1.21 Million Investment in Heartflow, Inc. $HTFL

Quantbot Technologies LP purchased a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 41,128 shares of the company’s stock, valued at approximately $1,207,000.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. bought a new position in shares of Heartflow in the third quarter worth about $48,871,000. Legal & General Group Plc bought a new stake in Heartflow during the 3rd quarter valued at approximately $59,000. Franklin Resources Inc. purchased a new position in Heartflow in the 3rd quarter worth approximately $10,829,000. UBS Group AG bought a new position in Heartflow in the 3rd quarter worth approximately $5,130,000. Finally, Sei Investments Co. purchased a new stake in Heartflow during the 3rd quarter valued at approximately $303,000.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on HTFL shares. Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Canaccord Genuity Group raised their target price on shares of Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, August 14th. Robert W. Baird set a $45.00 price target on shares of Heartflow in a report on Friday, August 14th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Finally, Morgan Stanley raised their price objective on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $43.43.

Heartflow Price Performance

Shares of HTFL opened at $49.89 on Wednesday. The business’s 50 day simple moving average is $31.36 and its 200-day simple moving average is $28.63. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $51.19. The stock has a market capitalization of $4.34 billion and a price-to-earnings ratio of -27.26.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company had revenue of $64.08 million for the quarter. The business’s revenue was up 47.7% compared to the same quarter last year. On average, sell-side analysts expect that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Insider Transactions at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $41.23, for a total value of $380,099.37. Following the completion of the transaction, the insider owned 86,459 shares in the company, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 27,230 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $50.00, for a total value of $1,361,500.00. Following the sale, the chief executive officer directly owned 360,814 shares in the company, valued at $18,040,700. The trade was a 7.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 191,271 shares of company stock worth $7,089,136. Insiders own 7.70% of the company’s stock.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.